Aristopharma launches Canalia Capsule

Canalia Capsule is the only US FDA approved Proton Pump Inhibitor formulated with Dual Delayed Release (DDR) technology that ensures both faster and longest action. Canalia Capsule ensures  24-hour heartburn free periods and with just one capsule provides similar effects as twice-daily conventional Proton Pump Inhibitors. Canalia Capsule is safe for cardiac patients as Dexlansoprazole has no clinically important effect on the active metabolite of Clopidogrel. It is a novel Proton Pump Inhibitor which doesn’t prolong QT intervals in healthy participants and is well-tolerated. So it is considered safe even for cardiac patients.